US 8012965
Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
granted A61PA61P13/12A61P17/06
Quick answer
US patent 8012965 (Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P13/12, A61P17/06, A61P19/00, A61P19/02